Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Differences in sensitivity to melphalan between con A-activated and nonactivated human T-cell subsets.

L Komlos, S Ben-Efraim, J Notmann

    Clinical Immunology and Immunopathology
    |October 1, 1987
    PubMed
    Summary

    Melphalan (L-PAM) treatment in vitro affects T-lymphocyte populations differently based on activation status. L-PAM alters the immunoregulatory circuit within activated T cells, impacting suppressor cell activity.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Ovarian function and body temperature.

    Lancet (London, England)·2010
    Same author

    Unsuspected genital tuberculosis as a main cause of tubal occlusion.

    Lancet (London, England)·2010
    Same author

    Experiences with artificial insemination.

    Human fertility·2010
    Same author

    Possible zoonotic transmission of toxigenic Corynebacterium ulcerans from companion animals in a human case of fatal diphtheria.

    The Veterinary record·2009
    Same author

    Illicit substance use and its correlates in first episode psychosis.

    Acta psychiatrica Scandinavica·2009
    Same author

    Oral-anal intercourse and sexual transmission of Enterobius vermicularis; do we need to screen for other intestinal parasites?

    International journal of STD & AIDS·2009

    Area of Science:

    • Immunology
    • Cell Biology
    • Pharmacology

    Background:

    • T lymphocytes play a crucial role in immune regulation.
    • Melphalan (L-PAM) is a chemotherapeutic agent with potential immunomodulatory effects.
    • Understanding T-cell subset sensitivity to L-PAM is vital for therapeutic applications.

    Purpose of the Study:

    • To investigate the in vitro effects of melphalan (L-PAM) on different T-lymphocyte subsets.
    • To determine how Concanavalin A (Con A) activation influences T-cell sensitivity to L-PAM.
    • To elucidate L-PAM's impact on the immunoregulatory circuit involving T-cell subsets.

    Main Methods:

    • In vitro treatment of human peripheral blood lymphocytes (PBL) with melphalan (L-PAM).
    • Flow cytometry analysis using T-cell specific markers (OKT3, OKT4, OKT8, OKT17).

    Related Experiment Videos

  • Functional assays assessing T-cell suppressive activity on PHA stimulation after L-PAM treatment and cell subset depletion.

    • Main Results:

    • L-PAM significantly decreased E-rosette-positive (E+) T cells, including OKT4 and OKT17 subsets, but not OKT8.
    • Con A activation altered T-cell sensitivity to L-PAM, affecting OKT3, OKT4, OKT8, and OKT17 antigen expression.
    • OKT17+ cells were identified as crucial suppressor cells within the Con A-activated OKT4 subset, and their depletion abolished suppression, which was restored by L-PAM treatment.

    Conclusions:

    • Concanavalin A activation modifies the sensitivity of T-cell phenotypes to melphalan (L-PAM).
    • Melphalan (L-PAM) appears to modulate the immunoregulatory circuit within activated T cells, particularly affecting suppressor cell function.
    • These findings highlight the complex interplay between L-PAM, T-cell activation, and immune regulation.